Exane Derivatives’s Wabtec WAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62
Closed -$5.96K 1002
2022
Q1
$5.96K Buy
+62
New +$5.74K ﹤0.01% 689
2021
Q4
Sell
-62
Closed -$5.34K 1050
2021
Q3
$5.34K Hold
62
﹤0.01% 732
2021
Q2
$5.13K Hold
62
﹤0.01% 770
2021
Q1
$4.91K Hold
62
﹤0.01% 621
2020
Q4
$4.54K Hold
62
﹤0.01% 564
2020
Q3
$3.84K Hold
62
﹤0.01% 524
2020
Q2
$3.57K Hold
62
﹤0.01% 472
2020
Q1
$2.98K Hold
62
﹤0.01% 479
2019
Q4
$4.86K Buy
+62
New +$4.59K ﹤0.01% 440
2019
Q1
Sell
-71
Closed -$4.99K 714
2018
Q4
$4.99K Hold
71
﹤0.01% 496
2018
Q3
$7.48K Hold
71
﹤0.01% 451
2018
Q2
$7.03K Hold
71
﹤0.01% 465
2018
Q1
$5.66K Hold
71
﹤0.01% 431
2017
Q4
$5.78K Sell
71
-1
-1% -$76 ﹤0.01% 422
2017
Q3
$5.45K Hold
72
﹤0.01% 422
2017
Q2
$6.59K Hold
72
﹤0.01% 424
2017
Q1
$5.62K Hold
72
﹤0.01% 373
2016
Q4
$5.98K Hold
72
﹤0.01% 428
2016
Q3
$5.88K Hold
72
﹤0.01% 434
2016
Q2
$5.06K Sell
72
-134
-65% -$10.4K ﹤0.01% 394
2016
Q1
$16.3K Sell
206
-56
-21% -$3.88K ﹤0.01% 387
2015
Q4
$18.6K Hold
262
﹤0.01% 299
2015
Q3
$23.1K Sell
262
-17
-6% -$1.62K ﹤0.01% 310
2015
Q2
$26.3K Sell
279
-355
-56% -$34.9K ﹤0.01% 325
2015
Q1
$60.2K Sell
634
-1,835
-74% -$165K 0.01% 300
2014
Q4
$215K Buy
+2,469
New +$208K 0.03% 205

Other funds holding WAB

Exane Derivatives's WAB Position: Q2 2022 in Review

Exane Derivatives sold out of Wabtec (WAB) in Q2 2022, closing a stake of 62 shares — an estimated $5.96K sold.

Exane Derivatives first reported a position in WAB in Q4 2014 and held it in 26 quarters. The position peaked at $215K in Q4 2014. 766 funds tracked by Wall St. Rank hold WAB as of Q2 2022.

  • Exane Derivatives reported no remaining Wabtec position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 62 Wabtec shares in Q2 2022, an estimated $5.96K.
  • Exane Derivatives first reported a position in Wabtec in Q4 2014 and held it in 26 quarters.
  • Exane Derivatives's Wabtec position peaked at $215K in Q4 2014.
  • 766 funds tracked by Wall St. Rank held Wabtec as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.